CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | January/February 2024

Provisional Versus Two-Stent Bifurcation PCI: Types of Bifurcation Stenting Techniques

A review of approaches to treat complex bifurcation lesions, including provisional stenting, T stent, TAP, crush techniques, and the culotte technique.

By Moemen Eltelbany, MD; Charlene L. Rohm, MD; Lindsey Cilia, MD; and Leah Raj, MD

cit | Article | January/February 2024

Complex PCI

By Rhian E. Davies, DO, MS, FACC, FSCAI

cit | News | March 16, 2019

TAVR Shown to Be Safe in Treating Patients With Bicuspid Valves

March 17, 2019—The American College of Cardiology (ACC) announced that findings from a trial studying transcatheter aortic valve replacement (TAVR) treatment of bicuspid valves in patients at intermediate or high surgical risk were presented by Lead Investigator Raj Makkar, MD, at the ACC's 68th Annual Scientific Session being held March 16–18 in New Orleans, Louisiana.

Sponsored by Penumbra, Inc.

cit | Article | March/April 2025

Penumbra’s Interventional Clot Removal Platform

With George Chrysant, MD; Nikoloz Shekiladze, MD; Raj Kakarla, MD; Anjan Gupta, MD, FACC, FSCAI; and Rafey Feroze, MD

Advertisement

Advertisement

cit | Article | May/June 2024

Transcatheter Tricuspid Valve Replacement With the Evoque Valve

A step-by-step guide to procedural technique, data, and future challenges.

By Aakriti Gupta, MD, MS; Moody Makar, MD; and Raj Makkar, MD

cit | Article | July/August 2010

Valve-in-Valve TAVI for Degenerated Surgical Prostheses

Transcatheter aortic valve implantation is being used in novel ways to treat degenerated surgical prostheses with promising results.

By Lucas W. Henn, MD; Raj R. Makkar, MD, FACC, FSCAI; and Gregory P. Fontana, MD, FACS, FACC

cit | News | July 2, 2025

MiRus Siegel 8-F TAVR System Evaluated in Early Feasibility Study

July 2, 2025—MiRus, LLC, announced the presentation of 30-day results from the United States early feasibility study (EFS) of the company’s Siegel transcatheter aortic valve replacement (TAVR) system.

cit | Article | March/April 2024

TAVR Update

By Vivian G. Ng, MD

cit | News | May 18, 2021

Edwards’ Sapien 3 TAVR Device Evaluated for Bicuspid Aortic Stenosis in Real-World TVT Registry

May 18, 2021—Edwards Lifesciences announced the results of a real-world study comparing outcomes for patients with bicuspid aortic stenosis (AS) who were treated with the company’s Sapien 3 and Sapien 3 Ultra transcatheter aortic valve replacement (TAVR) devices and were at low risk of death from surgery.

cit | News | April 9, 2026

STAR Trial of TAVR With MiRus’ Siegel THV Begins Enrollment

April 9, 2026—MiRus, LLC, announced commencement of enrollment and the treatment of the first patients in the STAR trial of transcatheter aortic valve replacement with the company’s Siegel 8-F transcatheter heart valve (THV).

cit | News | March 28, 2024

JenaValve’s ALIGN-AR Pivotal Trial Results for Trilogy THV System Are Published

March 28, 2024—JenaValve Technology, Inc. announced the publication of results from the ALIGN-AR pivotal trial, which is a prospective, multicenter study evaluating the use of the company’s Trilogy transcatheter heart valve (THV) system in high-risk patients with symptomatic moderate-to-severe or severe aortic regurgitation (AR).

cit | News | June 15, 2021

JenaValve Reaches Milestone in ALIGN-AR Trial Enrollment of Trilogy TAVR System

June 15, 2021—JenaValve Technology, Inc., developer of a transcatheter aortic valve replacement (TAVR) system, announced a milestone in enrollment for its ALIGN-AR clinical trial of the company’s Trilogy heart valve system.

cit | News | May 12, 2014

St. Jude Medical Begins US Trial of Portico TAVR System

May 13, 2014—St.


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button